Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast media (non‑ionic, low‑osmolar) presented as a solution for injection for intraarterial, intraarticular, and intrathecal use. It enhances radiographic visualization of vascular and tissue structures during imaging procedures in patients undergoing angiography, arthrography, myelography, or computed tomography scans.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution, ensuring reliable supply chains and timely delivery.

Iomeron is an iodinated contrast agent that improves imaging of vascular and musculoskeletal structures during diagnostic procedures. - Angiography: provides enhanced visualization of blood vessels and arterial anatomy. - Arthrography: delineates joint spaces, cartilage, and surrounding soft tissues for orthopedic assessment. - Myelography: improves contrast of the spinal canal and nerve roots during intrathecal imaging. - Computed tomography (CT) imaging: increases attenuation of tissues, allowing clearer differentiation of organs and lesions.

Iomeron may be associated with a range of adverse reactions, most of which are mild and transient. Common Side Effects: - Warm sensation or flushing: brief feeling of heat during injection. - Metallic taste: transient metallic flavor in the mouth. - Nausea or vomiting: mild gastrointestinal upset. Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rapid onset of breathing difficulty, hypotension, or rash. - Contrast‑induced nephropathy: sudden decline in renal function, especially in patients with pre‑existing kidney disease. - Cardiac arrhythmias: irregular heart rhythms during or after injection.

Prior to administering Iomeron, clinicians should observe several precautionary measures to minimize risk and ensure patient safety. - Assess renal function: evaluate eGFR or serum creatinine before use. - Screen for iodine allergy: obtain detailed history of hypersensitivity to contrast agents. - Ensure adequate hydration: encourage fluid intake before and after the procedure. - Use lowest effective volume: tailor contrast dose to patient size and imaging requirement. - Monitor patient closely: observe vital signs and watch for immediate reactions during and after injection. - Store at ambient temperature: keep in original container, protect from light and moisture.

Iomeron can interact with certain medications, requiring attention to avoid adverse outcomes. Major Interactions (Avoid): - Metformin: risk of lactic acidosis; discontinue before and after contrast exposure in patients with renal impairment. - High‑dose iodine‑containing drugs (thyroid hormone, amiodarone): may exacerbate iodine load and affect thyroid function. - Nephrotoxic agents (aminoglycosides, NSAIDs, IV contrast): increase risk of renal injury; avoid concurrent use. Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask tachycardia signs of an allergic reaction. - Diuretics: can affect fluid balance and renal clearance of contrast. - ACE inhibitors or ARBs: may potentiate contrast‑induced nephropathy; monitor renal function.